SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

365.9334533

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

34.95

70623.18

EPS(TTM)

Face Value()

Div & Yield %

34.49

Back

the ramco cements ltd

Solana Biofuels reports standalone net loss of Rs 2.78 crore in the September 2025 quarter

Nov 16,2025

Net Loss of Solana Biofuels reported to Rs 2.78 crore in the quarter ended September 2025 as against net loss of Rs 0.81 crore during the previous quarter ended September 2024. Sales declined 58.16% to Rs 18.67 crore in the quarter ended September 2025 as against Rs 44.62 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	18.67	44.62	-58
OPM %	-6.53	1.14	-
PBDT	-1.85	0	0
PBT	-2.78	-0.95	-193
NP	-2.78	-0.81	-243

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)